BIO-TECHNE Corp (TECH)

SEC filing

BIO-TECHNE Corp

TECH · CIK 842023

4 · Aug 18, 2026 · Director, Chief Executive Officer Kelderman Kim exercised options for 42.94K shares; reported 10.82K shares; reported 63.87K shares

Director, Chief Executive Officer Kelderman Kim exercised options for 42.94K shares; reported 10.82K shares; reported 63.87K shares

Filed: Aug 18, 2026
Period: Aug 15, 2026
Accession: 0000914190-26-000122
Filer: BIO-TECHNE Corp

View on SEC.gov All SEC filings

Filing document

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov